News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
The Coalition of State Bioscience Institutes …
"The intense competition for talent in 2021, 2022 and into early 2023 extended to the life sciences as the nation’s overall unemployment rate reached                            …
Massachusetts Speaker of the House Ron Mariano…
Today, the Biotechnology Innovation Organization (BIO) presented Speaker of the Massachusetts House of Representatives Ronald J. Mariano with BIO’s Legislative Champion Award. Speaker Mariano received the award in conjunction with the BIO…
New Report Explores Latest Best Practices in…
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences…
Letters, Testimony, & Comments
BIO Testimony on Restoring R&D Tax Deduction
Biotechnology Innovation Organization statement for the record to the U.S. House Committee on Small Business Subcommittee on Economic Growth, Tax, and Capital Access hearing on "American Ingenuity: Promoting Innovation Through the Tax Code…
Testimony on Intellectual Property Protections in…
The global IP framework has enabled lifesaving innovation and provides a reliable legal foundation for companies to voluntarily license their IP to enhance research collaborations and provide timely, equitable global access to safe and effective…
BIO Comments to FDA (Docket No. FDA-2023-N-0398)…
In these comments, BIO addresses FDA’s four specific topic areas of consideration as the agency develops its draft guidance per PDUFA VII.
Amicus Briefs
BIO Files Amicus Brief in U.S. ex rel. Scutte v…
BIO has filed an amicus brief in U.S. ex rel. Scutte v. SuperValu Inc., which addresses the issue of the intent requirement under the False Claims Act (FCA). Specifically, BIO urges the Court to uphold the view that a firm does not…
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S…
The Biotechnology Innovation Organization (BIO) today signed onto an amicus brief to challenge a District Court’s unprecedented ruling (related to a single drug known as mifepristone) that would create regulatory barriers and potentially upend FDA’s…
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Placeholder Image
March 19, 2023
Biotech is a cornerstone to serving the world’s health-related needs for all demographics; but in the United States, the industry’s workforce does not reflect the demographics it serves, to the detriment of both the…
Placeholder Image
June 7, 2022
Thousands of global biotechnology and biopharmaceutical leaders will gather at the 2022 BIO International Convention in San Diego June 13-16 for four exciting days of networking, programming, and partnering…
primetime life sciences
June 6, 2022
The 2022 BIO International Convention is back and in person this year. Thousands of global biotechnology and biopharmaceutical leaders will gather in San Diego as we celebrate how scientific discoveries and innovations…